Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Livermore, Derek Brown (2001)
Detection of β-lactamase-mediated resistanceJournal of Antimicrobial Chemotherapy, 48
K. Thomson (2001)
Controversies about extended-spectrum and AmpC beta-lactamases.Emerging Infectious Diseases, 7
P. Midolo, D. Matthews, Carla Fernandez, T. Kerr (2002)
Detection of extended spectrum β‐lactamases in the routine clinical microbiology laboratoryPathology, 34
J. Andrews (2001)
Determination of minimum inhibitory concentrations.The Journal of antimicrobial chemotherapy, 48 Suppl 1
E. Stürenburg, I. Sobottka, H. Feucht, D. Mack, R. Laufs (2003)
Comparison of BDPhoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates.Diagnostic microbiology and infectious disease, 45 1
Correspondence ParC proteins. The results show that the use of 20 mg/L of Phe-Arg- References β-naphthylamide decreased the MIC of nalidixic acid (from two to 1. Everett, M. J., Fang Jin, Y., Ricci, V. et al. (1996). Contributions of five serial two-fold dilution steps) in all isolates tested, even in those individual mechanisms to fluoroquinolone resistance in 36 Escherichia with the nalidixic acid-susceptible phenotype. This high reduction in coli strains isolated from humans and animals. Antimicrobial Agents and the MIC values was observed independent of the number of amino Chemotherapy 40, 2380–6. acid changes in GyrA and ParC. This effect was especially noticeable 2. Lomovskaya, O., Warren, M. S., Lee, A. et al. (2001). Identification among isolates carrying one single GyrA substitution, in which the and characterization of inhibitors of multidrug resistance efflux pumps in MIC of nalidixic acid decreased from resistant to susceptible levels Pseudomonas aeruginosa: novel agents for combination therapy. Anti- (from 128 to 8 mg/L). This result indicates that one amino acid change microbial Agents and Chemotherapy 45, 105–16. in GyrA by itself (without an additional mechanism of resistance) is 3. Malléa, M., Mahamoud, A., Chevalier, J. et al. (2003). Alkylamino- unable to confer a resistant
Journal of Antimicrobial Chemotherapy – Oxford University Press
Published: Mar 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.